Story detail view · 2026-07
STAT+: Merck strikes voluntary licensing deals in poor countries for an experimental HIV prevention pill

STAT+: Merck strikes voluntary licensing deals in poor countries for an experimental HIV prevention pill

Quick Summary

Merck is striking licensing deals for its experimental HIV prevention pill in hope of getting wide-scale production started quickly.

Continue Reading on STAT News

Get instant updates on Telegram

Join our channel to receive the latest headlines and breaking stories as soon as they are published.

Join channel

Comments (0)

Join the conversation. Comments are rate-limited, secured, and GDPR-compliant.

No comments yet. Be the first to share your thoughts!

Write a comment

0 / 500